EMD-52411

Single-particle
2.97 Å
EMD-52411 Deposition: 22/12/2024
Map released: 25/02/2026
Last modified: 19/08/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-52411

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9hug summary report (pdf.gz) Map-9hug FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Inward-open structure of human glycine transporter 2 in substrate-free state

EMD-52411

Single-particle
2.97 Å
EMD-52411 Deposition: 22/12/2024
Map released: 25/02/2026
Last modified: 19/08/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Human glycine transporter GlyT2 in substrate-free state
Fitted models: 9hug

Deposition Authors: Cantwell Chater RP , Peiser-Oliver J, Pati TK, Quinn AS, Lotsaris I , Frangos ZJ , Anderson KE , Tischer AE , Williams-Noonan BJ, Aubrey KR , O Mara ML, Michaelides M , Mohammadi SA , Cioffi CL , Vandenberg RJ , Shahsavar A
A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects.
PUBMED: 41698908
DOI: doi:10.1038/s41467-026-69616-5
ISSN: 2041-1723